MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 45 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122,640 | -61.2% | 207,164 | -1.8% | 0.00% | – |
| Q2 2023 | $316,448 | -10.1% | 210,965 | +3.1% | 0.00% | – |
| Q1 2023 | $352,010 | +55.1% | 204,657 | +3.7% | 0.00% | – |
| Q4 2022 | $226,920 | -55.5% | 197,321 | +1.0% | 0.00% | – |
| Q3 2022 | $510,000 | +18.1% | 195,461 | -1.7% | 0.00% | – |
| Q2 2022 | $432,000 | -54.4% | 198,930 | -2.3% | 0.00% | – |
| Q1 2022 | $948,000 | -25.7% | 203,521 | -3.3% | 0.00% | – |
| Q4 2021 | $1,276,000 | +20.8% | 210,500 | +43.6% | 0.00% | – |
| Q3 2021 | $1,056,000 | +62.5% | 146,633 | +42.3% | 0.00% | – |
| Q2 2021 | $650,000 | – | 103,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 309,178 | $671,000 | 0.14% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
| Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
| Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
| M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
| Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
| Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |